Insights On Outsourced Drug Development
-
The People Who Turn An Idea Into A Deliverable Product
9/15/2026
Drug developers and device engineers share more common ground than their distinct disciplines suggest, facing parallel pressures around design, safety, regulatory approval, and scalable performance.
-
Detect Low-Abundance GLP-1 Impurities With Greater Sensitivity
8/24/2026
Low-level impurities can be difficult to resolve using conventional approaches. Discover how a Charged Surface 2.3 µm superficially porous Phenyl-Hexyl column enhances reversed-phase LC-MS analysis.
-
Development Of A High Sensitivity SPE-LC-MS/MS Assay
7/29/2025
Achieve ultra-sensitive glucagon quantification with ionKey/MS, μElution SPE, and advanced MS fragmentation to deliver low LOD, reduced sample loss, and enhanced confidence in results.
-
Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines
3/24/2025
Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.
-
Advancing Cell Culture Strategies To Accelerate Biologics Development
5/5/2026
Integrated stable expression strategies accelerate biologics material generation, improving scalability, consistency, and early developability insights while reducing bottlenecks, variability, and risks in transitioning from discovery to manufacturing.
-
Biophysical Tools For Biotherapeutic Development
6/26/2025
Discover essential analytical techniques in biotherapeutics development, as well as explore ITC, DSC, and Rheology—powerful tools for understanding formulation, stability, and efficacy in drug development.
-
Selecting A CDMO For Custom Activated PEGs
1/27/2026
Custom-activated PEGs require thoughtful planning and precise analytical control. Discover key considerations for selecting a partner capable of supporting scalable, compliant PEGylation.
-
Predicting Softgel Stability And Shelf Life Using Accelerated Modeling
7/15/2026
Predict ibuprofen softgel shelf life in 21 days instead of years. ASAPprime modeling identified PEG-ester degradants as the limiting factor, estimating 5.5-year and 3.8-year shelf lives before long-term studies concluded.
-
De-Risking Complex Generic OSD Development
10/13/2026
Complex generic tablet development requires early alignment of regulatory strategy, QbD formulation, discriminatory dissolution, and reference-scaled bioequivalence.
-
Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery
6/3/2025
Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.